EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Monitoring α-synuclein Aggregation Induced by Preformed α-synuclein Fibrils in an In Vitro Model System

Beom Jin Kim, Hye Rin Noh, Hyongjun Jeon, Sang Myun Park

Experimental Neurobiology · 30.06.2023 · 32 (3) · 147-156

DOI: 10.5607/en23007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Neurobiology, erschienen am 30.06.2023. Verfasst von Beom Jin Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Ajou University School of Medicine, Suwon 16499, Korea. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is characterized by the presence of α-synuclein (α-syn) inclusions in the brain and the degeneration of dopamine-producing neurons. There is evidence to suggest that the progression of PD may be due to the prion-like spread of α-syn aggregates, so understanding and limiting α-syn propagation is a key area of research for developing PD treatments. Several cellular and animal model systems have been established to monitor α-syn aggregation and propagation. In this study, we developed an in vitro model using A53T α-syn-EGFP overexpressing SH-SY5Y cells and validated its usefulness for high-throughput screening of potential therapeutic targets. Treatment with preformed recombinant α-syn fibrils induced the formation of aggregation puncta of A53T α-syn-EGFP in these cells, which were analyzed using four indices: number of dots per cell, size of dots, intensity of dots, and percentage of cells containing aggregation puncta. Four indices are reliable indicators of the effectiveness of interventions against α-syn propagation in a one-day treatment model to minimize the screening time. This simple and efficient in vitro model system can be used for high-throughput screening to discover new targets for inhibiting α-syn propagation.

Schlagwörter

Stichwörter der Autor:innen

In vitro techniquesParkinson diseaseProtein aggregationα-synuclein

Autor:innen und Institutionen

  • Department of Pharmacology, Ajou University School of Medicine, Suwon 16499, Korea.
  • Center for Convergence Research of Neurological Disorders, Ajou University School of Medicine, Suwon 16499, Korea.
  • Neuroscience Graduate Program, Department of Biomedical Sciences, Ajou University School of Medicine, Suwon 16499, Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT

Zitieren

APA

Kim, B. J., Noh, H. R., Jeon, H., & Park, S. M. (2023). Monitoring α-synuclein Aggregation Induced by Preformed α-synuclein Fibrils in an In Vitro Model System. Experimental Neurobiology, 32(3), 147-156. https://doi.org/10.5607/en23007

Vancouver

Kim BJ, Noh HR, Jeon H, Park SM. Monitoring α-synuclein Aggregation Induced by Preformed α-synuclein Fibrils in an In Vitro Model System. Experimental Neurobiology. 2023;32(3):147-156. doi:10.5607/en23007

BibTeX
@article{Kim2023,
  author = {Kim, Beom Jin and Noh, Hye Rin and Jeon, Hyongjun and Park, Sang Myun},
  title = {Monitoring α-synuclein Aggregation Induced by Preformed α-synuclein Fibrils in an In Vitro Model System},
  journal = {Experimental Neurobiology},
  year = {2023},
  volume = {32},
  number = {3},
  pages = {147--156},
  doi = {10.5607/en23007}
}
Kostenlos starten →